药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Granisetron
Raclopride
The risk or severity of adverse effects can be increased when Vecuronium is combined with Raclopride.
Granisetron
Ketanserin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Ketanserin.
Granisetron
Orvepitant
The risk or severity of adverse effects can be increased when Vecuronium is combined with Orvepitant.
Granisetron
Bromperidol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Bromperidol.
Granisetron
Esreboxetine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Esreboxetine.
Granisetron
Piclozotan
The risk or severity of adverse effects can be increased when Vecuronium is combined with Piclozotan.
Granisetron
Carisbamate
The risk or severity of adverse effects can be increased when Vecuronium is combined with Carisbamate.
Granisetron
Salvinorin A
The risk or severity of adverse effects can be increased when Vecuronium is combined with Salvinorin A.
Granisetron
Eltanolone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Eltanolone.
Granisetron
Ecopipam
The risk or severity of adverse effects can be increased when Vecuronium is combined with Ecopipam.
Granisetron
Cerlapirdine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Cerlapirdine.
Granisetron
Gepirone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Gepirone.
Granisetron
Eplivanserin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Eplivanserin.
Granisetron
Sarpogrelate
The risk or severity of adverse effects can be increased when Vecuronium is combined with Sarpogrelate.
Granisetron
MK-212
The risk or severity of adverse effects can be increased when Vecuronium is combined with MK-212.
Granisetron
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Vecuronium is combined with m-Chlorophenylpiperazine.
Granisetron
Imagabalin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Imagabalin.
Granisetron
Vabicaserin
The risk or severity of adverse effects can be increased when Vecuronium is combined with Vabicaserin.
Granisetron
Idalopirdine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Idalopirdine.
Granisetron
Lanicemine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Lanicemine.